Medivizor

Title of notification

Here comes the notification
X
 
icon
icon
non-hodgkin lymphoma | Research | Treatment | 10 pages | source: The Lancet. Haematology | Added Apr 23, 2025

How safe and effective is the combination of ibrutinib, lenalidomide, and rituximab for relapsed or refractory mantle cell lymphoma?

This study investigated the safety and effectiveness of ibrutinib (Imbruvica), lenalidomide (Revlimid), and rituximab (Rituxan) given together to patients with relapsed or refractory (not responding to treatment) mantle cell lymphoma (MCL). The authors conclude that this combination is effective in these patients, but not better than the combination of lenalidomide and rituximab or ibrutinib alone.

icon
diabetes mellitus | Medivizor | source: Medivizor | Added Apr 22, 2025

What’s going on with the price of Insulin?

And the prices of other medications in the US Type 1 diabetes is an autoimmune disease. That means that the person’s immune system attacks and destroys the cells in the pancreas (beta cells) that make insulin. Once those cells are destroyed, they don’t grow back. Type 1 diabetes is usually
icon
icon
erectile dysfunction | Research | Treatment | 10 pages | source: The journal of sexual medicine | Added Apr 21, 2025

Which is the best form to take sildenafil?

This study compared the safety and effectiveness of sildenafil (Viagra) taken as a film-coated tablet (FCT - swallowed) and oro-dispersible film (ODF – dissolved in the mouth). The study found that FCT and ODF had the same effectiveness but that patients preferred ODF.

icon
icon
colorectal cancer | Research | Lifestyle | 9 pages | source: British Journal of Cancer | Added Apr 21, 2025

Do other illnesses influence survival?

This study aims to evaluate the effect of other concurrent illnesses (comorbidities) on the survival of patients with colorectal cancer (CRC).

icon
icon
non-hodgkin lymphoma | Research | Treatment | 10 pages | source: Therapeutic Advances in Hematology | Added Apr 20, 2025

Lenalidomide treatment for B-cell non-Hodgkin lymphomas

This study reviewed the use of lenalidomide (Revlimid) in B-cell non-Hodgkin lymphomas.

icon
diabetes mellitus | Medivizor | source: Medivizor | Added Apr 20, 2025

Diabetes Burnout

"I just don't think about my diabetes. It's too complicated and I'm too busy." "I've given up on carb counting and just eat whatever." "If my blood sugar is out of range, I just don't care." "Family and friends don't support me. " "I feel hopeless." If these statements sound
icon
colorectal cancer | Research | 8 pages | source: Diseases of the colon and rectum | Added Apr 19, 2025

Ureteral injuries during colorectal surgery

This study analyzed the incidence and risk of ureteral injuries following colorectal surgery.

icon
diabetes mellitus | Medivizor | source: Medivizor | Added Apr 18, 2025

Brain Vs Pancreas: Complications of Diabetes

How healthy is my brain? This a question you probably should be asking yourself.  That is, for the around 9% (about 350 million) of the world population diagnosed with diabetes, 29 million of whom live in the US, research recommends making brain health a top priority. Diabetes and Brain Health Research
icon
icon
erectile dysfunction | Research | Treatment | 10 pages | source: Andrology | Added Apr 17, 2025

Traditional Chinese medicine combined with tadalafil improves the outcomes of patients with erectile dysfunction

This study investigated the effectiveness of traditional Chinese medicine (TCM) with tadalafil (Cialis) to treat erectile dysfunction (ED). Researchers suggested that this treatment helps treat ED with no increase in side effects. 

icon
colorectal cancer | Research | 9 pages | source: Cancer | Added Apr 17, 2025

BRAF mutations predict poorer outcomes for colorectal cancer patients

This study examined the implications of having a BRAF mutation for patients with colorectal cancer that has spread (metastasized). 

View

Conditions

Category

  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon

Was this helpful?